214 related articles for article (PubMed ID: 17506275)
1. [Precancerous lesions of the uterine cervix in Pointe-Noire, Congo].
Moukassa D; N'Golet A; Lingouala LG; Eouani ML; Samba JB; Mambou JV; Ompaligoli S; Moukengue LF; Taty-Pambou E
Med Trop (Mars); 2007 Feb; 67(1):57-60. PubMed ID: 17506275
[TBL] [Abstract][Full Text] [Related]
2. [Counseling protocol for early cancer detection at the Women's Health Center in Ruma].
Nedić B; Ravić J; Loncar S; Cuk D
Med Pregl; 1999; 52(3-5):162-4. PubMed ID: 10518403
[TBL] [Abstract][Full Text] [Related]
3. [Are analyses of cytological cervix smears from young women more harmful than beneficial?].
Skjeldestad FE; Hagen B; Hagmar B; Iversen OE; Juvkam KH; Steen R; Thoresen S; Hareide B
Tidsskr Nor Laegeforen; 2007 Jun; 127(13):1782-5. PubMed ID: 17599128
[TBL] [Abstract][Full Text] [Related]
4. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
Schindeler S; Morrell S; Zuo Y; Baker D
J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
[TBL] [Abstract][Full Text] [Related]
5. Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample.
Zhao C; Austin RM
Cancer; 2008 Aug; 114(4):242-8. PubMed ID: 18484643
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
[TBL] [Abstract][Full Text] [Related]
7. [Precancerous lesions of the uterine cervix in cameroonian women. Cytological and epidemiological aspects of 946 cases].
Nkegoum B; Belley Priso E; Mbakop A; Gwent Bell E
Gynecol Obstet Fertil; 2001 Jan; 29(1):15-20. PubMed ID: 11217188
[TBL] [Abstract][Full Text] [Related]
8. [Premalignant and malignant changes in the uterine cervix in women younger than 30 years].
Postruznik S; Jurić M; Giljanović L; Strmo V
Jugosl Ginekol Perinatol; 1985; 25(5-6):121-4. PubMed ID: 3837134
[TBL] [Abstract][Full Text] [Related]
9. [Value and limits of cytology in the diagnosis of cervico-vaginal lesions at the Mahajanga University Hospital Center: 465 cases].
Ravolamanana Ralisata L; Randrianjafisamindrakotroka NS; Rakoto EB; Ranaivozanany A
Arch Inst Pasteur Madagascar; 1999; 65(1-2):120-3. PubMed ID: 12478977
[TBL] [Abstract][Full Text] [Related]
10. [The incidence of borderline and pathologic findings in young females within the scope of gynecologic-cytologic screening studies].
Neumann HG; Barten G; Barten M; Schröder M
Zentralbl Gynakol; 1989; 111(14):947-51. PubMed ID: 2800778
[TBL] [Abstract][Full Text] [Related]
11. [Cervical cancers diagnosed at the Pasteur Institute of Madagascar from 1992 to 2002].
Raharisolo Vololonantenaina CR; Rabarijaona LP; Soares JL; Rasendramino M; Pécarrère JL; Khun H; Huerre M
Arch Inst Pasteur Madagascar; 2003; 69(1-2):77-81. PubMed ID: 15678821
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy.
Agarossi A; Ferrazzi E; Parazzini F; Perno CF; Ghisoni L
J Med Virol; 2009 Mar; 81(3):529-35. PubMed ID: 19152401
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus DNA detection in ThinPrep Pap test vials is independent of cytologic sampling of the transformation zone.
Zhao C; Austin RM
Gynecol Oncol; 2007 Nov; 107(2):231-5. PubMed ID: 17854873
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of adding human papilloma virus testing to a managed care cervical cancer screening program.
Lonky NM; Hunter MI; Sadeghi M; Edwards G; Bajamundi K; Monk BJ
J Low Genit Tract Dis; 2007 Oct; 11(4):258-64. PubMed ID: 17917570
[TBL] [Abstract][Full Text] [Related]
15. [The role of sexual activity in the development of precancerous and early stages of cervix cancer].
Barten G
Zentralbl Gynakol; 1990; 112(3):143-50. PubMed ID: 2336889
[TBL] [Abstract][Full Text] [Related]
16. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1.
Jordan J; Arbyn M; Martin-Hirsch P; Schenck U; Baldauf JJ; Da Silva D; Anttila A; Nieminen P; Prendiville W
Cytopathology; 2008 Dec; 19(6):342-54. PubMed ID: 19040546
[TBL] [Abstract][Full Text] [Related]
17. Changing patterns in cervical cytology among oral and non-oral contraceptive users.
Fuertes-de la Haba A; Pelegrina I; Bangdiwala IS; Hernández-Cibes JJ
J Reprod Med; 1973 Jan; 10(1):3-10. PubMed ID: 4572229
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and genotype distribution of multiple human papillomavirus infection in the uterine cervix: a 7.5-year longitudinal study in a routine cytology-based screening population in West Germany.
Kovács K; Varnai AD; Bollmann M; Bankfalvi A; Szendy M; Speich N; Schmitt C; Pajor L; Bollmann R
J Med Virol; 2008 Oct; 80(10):1814-23. PubMed ID: 18712836
[TBL] [Abstract][Full Text] [Related]
19. [Human papillomavirus genotype profile in Kinshasa, Democratic Republic of the Congo: implications for vaccination].
Ali-Risasi C; Praet M; Van Renterghem L; Zinga-Ilunga B; Sengeyi D; Lokomba V; Mukamina L; Ndarabu A; Kayembe NN; Tshilolo L; Mukumbi MH
Med Trop (Mars); 2008 Dec; 68(6):617-20. PubMed ID: 19639831
[TBL] [Abstract][Full Text] [Related]
20. [Usefulness of HPV test on cell sample from the cervix].
Vintermyr OK; Skar R; Iversen OE; Haugland HK
Tidsskr Nor Laegeforen; 2008 Jan; 128(2):171-3. PubMed ID: 18202727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
